Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease

IMPORTANCE: Blood-based tests for brain amyloid-β (Aβ) pathology are needed for widespread implementation of Alzheimer disease (AD) biomarkers in clinical care and to facilitate patient screening and monitoring of treatment responses in clinical trials. OBJECTIVE: To compare the performance of plasm...

Descripción completa

Detalles Bibliográficos
Autores principales: Janelidze, Shorena, Teunissen, Charlotte E., Zetterberg, Henrik, Allué, José Antonio, Sarasa, Leticia, Eichenlaub, Udo, Bittner, Tobias, Ovod, Vitaliy, Verberk, Inge M. W., Toba, Kenji, Nakamura, Akinori, Bateman, Randall J., Blennow, Kaj, Hansson, Oskar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453354/
https://www.ncbi.nlm.nih.gov/pubmed/34542571
http://dx.doi.org/10.1001/jamaneurol.2021.3180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453354/
https://www.ncbi.nlm.nih.gov/pubmed/34542571
http://dx.doi.org/10.1001/jamaneurol.2021.3180

Ejemplares similares